Extreme polyvalency induces potent cross-clade cellular and humoral responses in rabbits and non-human primates
US10828363B1 · kind B1 · utility
1Cited by
1References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 15, 2017 |
| Grant date | Nov 10, 2020 |
| Priority date | — |
| Expiry date | Sep 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising two or more DNA plasmids encoding consensus and transmitted founder HIV envelope glycoproteins which expressed and induce a potent immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.